HEMA.TO Trademark
HEMA.TO is a USPTO trademark filed by hema.to GmbH. Status: Registered.
Trademark Facts
| Mark | HEMA.TO |
|---|---|
| Serial Number | 79387054 |
| Registration Number | 7532658 |
| Status | Registered |
| Filing Date | 2023-08-08 |
| Registration Date | 2024-10-15 |
| Mark Type | Word |
| Nice Classes | 009 (Electronics & Software), 035 (Advertising & Business), 042 (Software & IT), 044 (Medical Services), 045 (Legal Services) |
| Owner | hema.to GmbH |
| Attorney of Record | Alexander Lazouski |
| Prosecution Events | 26 |
| Latest Event | OPNX on 2025-06-20 |
Goods & Services
Data processing equipment; computers; downloadable computer software for the collection, editing, organizing, modifying, book marking, transmission, storage, and sharing of data and information; all of the foregoing goods being solely in the fields of diagnostics, prognosis and therapy in connection with immunology and haemato-oncology; Business management; business administration; business consultancy and advisory services; Licensing of intellectual property rights, licensing of industrial property rights and other licensing of intellectual property rights of all kinds in the field of trademarks, patents, copyrights; Consulting services in the field of healthcare; Scientific and technological services and research, namely, scientific research, analysis, testing in the field of diagnostics, prognosis and therapy in connection with immunology and haemato-oncology; industrial analysis and research services in the field of diagnostics, prognosis and therapy in connection with immunology and haemato-oncology; design and development of computer hardware and software; hosting services, namely, hosting computer software applications, website hosting services; software as a service featuring software for the collection, editing, organizing, modifying, book marking, transmission, storage, and sharing of data and information; rental of software for the collection, editing, organizing, modifying, book marking, transmission, storage, and sharing of data and information; all of the foregoing services being solely in the fields of diagnostics, prognosis and therapy in connection with immunology and haematooncology